- Home
- CLCO vs GHRS Comparison
CLCO vs GHRS Comparison
Compare CLCO & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLCO
- GHRS
- Stock Information
- Founded
- CLCO 2018
- GHRS 2018
- Country
- CLCO United Kingdom
- GHRS Ireland
- Employees
- CLCO N/A
- GHRS N/A
- Industry
- CLCO
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- CLCO
- GHRS Health Care
- Exchange
- CLCO Nasdaq
- GHRS Nasdaq
- Market Cap
- CLCO 417.5M
- GHRS 462.0M
- IPO Year
- CLCO N/A
- GHRS 2021
- Fundamental
- Price
- CLCO $8.65
- GHRS $8.83
- Analyst Decision
- CLCO
- GHRS Strong Buy
- Analyst Count
- CLCO 0
- GHRS 3
- Target Price
- CLCO N/A
- GHRS $35.67
- AVG Volume (30 Days)
- CLCO 177.3K
- GHRS 91.0K
- Earning Date
- CLCO 02-26-2025
- GHRS 02-27-2025
- Dividend Yield
- CLCO 6.93%
- GHRS N/A
- EPS Growth
- CLCO N/A
- GHRS N/A
- EPS
- CLCO 1.73
- GHRS N/A
- Revenue
- CLCO $333,653,000.00
- GHRS N/A
- Revenue This Year
- CLCO N/A
- GHRS N/A
- Revenue Next Year
- CLCO $2.93
- GHRS N/A
- P/E Ratio
- CLCO $5.00
- GHRS N/A
- Revenue Growth
- CLCO N/A
- GHRS N/A
- 52 Week Low
- CLCO $6.92
- GHRS $6.00
- 52 Week High
- CLCO $13.68
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- CLCO 55.99
- GHRS 55.83
- Support Level
- CLCO $8.57
- GHRS $8.50
- Resistance Level
- CLCO $8.96
- GHRS $9.33
- Average True Range (ATR)
- CLCO 0.28
- GHRS 0.78
- MACD
- CLCO 0.07
- GHRS 0.06
- Stochastic Oscillator
- CLCO 55.95
- GHRS 44.20
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.